Publications

Export 196 results:
Sort by: Author [ Title (Desc)] Type Year
Filters: Author is Fox, Keith A A  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Y
Fox KA, Simpson IA, Lüscher TF. The Year in Cardiology series: the most recent advances in a nutshell for the readers of the European Heart Journal. Eur Heart J. 2013;34(4):307.
V
Morrow DA, Braunwald E, Bonaca MP, Ameriso SF, Dalby AJ, Fish MP, et al. Vorapaxar in the secondary prevention of atherothrombotic events. N Engl J Med. 2012;366(15):1404-13. Abstract
Morrow DA, Braunwald E, Bonaca MP, Ameriso SF, Dalby AJ, Fish MP, et al. Vorapaxar in the secondary prevention of atherothrombotic events. N Engl J Med. 2012;366(15):1404-13. Abstract
Morrow DA, Braunwald E, Bonaca MP, Ameriso SF, Dalby AJ, Fish MP, et al. Vorapaxar in the secondary prevention of atherothrombotic events. N Engl J Med. 2012;366(15):1404-13. Abstract
Cruden NL, Lang NN, Macgillivray TJ, Uren NG, Fox KA, Newby DE. Vasomotor and fibrinolytic responses to kinin receptor agonists in the atherosclerotic human lower limb. Heart and vessels. 2011. Abstract
Lang NN, Cruden NL, Tse GH, Bloomfield P, Ludlam CA, Fox KA, et al. Vascular B1 kinin receptors in patients with congestive heart failure. J Cardiovasc Pharmacol. 2008;52(5):438-44. Abstract
Buysschaert I, Carruthers KF, Dunbar DR, Peuteman G, Rietzschel E, Belmans A, et al. A variant at chromosome 9p21 is associated with recurrent myocardial infarction and cardiac death after acute coronary syndrome: the GRACE Genetics Study. European heart journal. 2010;31:1132-41. Abstract
Alhadi HA, Fox KA. Validity of Cardiac Markers as Diagnostic and Prognostic Indicators of Complications in Patients undergoing Percutaneous Coronary Intervention. Sultan Qaboos Univ Med J. 2010;10(1):31-40. Abstract
Alhadi HA, Fox KA. Validity of Cardiac Markers as Diagnostic and Prognostic Indicators of Complications in Patients undergoing Percutaneous Coronary Intervention. Sultan Qaboos Univ Med J. 2010;10(1):31-40. Abstract
Pieper KS, Gore JM, FitzGerald G, Granger CB, Goldberg RJ, Steg G, et al. Validity of a risk-prediction tool for hospital mortality: the Global Registry of Acute Coronary Events. Am Heart J. 2009;157(6):1097-105. Abstract
U
Damman P, Holmvang L, Tijssen JG, Lagerqvist B, Clayton TC, Pocock SJ, et al. Usefulness of the Admission Electrocardiogram to Predict Long-Term Outcomes After Non-ST-Elevation Acute Coronary Syndrome (from the FRISC II, ICTUS, and RITA-3 [FIR] Trials). The American journal of cardiology. 2011. Abstract
Damman P, Holmvang L, Tijssen JG, Lagerqvist B, Clayton TC, Pocock SJ, et al. Usefulness of the admission electrocardiogram to predict long-term outcomes after non-ST-elevation acute coronary syndrome (from the FRISC II, ICTUS, and RITA-3 [FIR] Trials). Am J Cardiol. 2012;109(1):6-12. Abstract
Damman P, Holmvang L, Tijssen JG, Lagerqvist B, Clayton TC, Pocock SJ, et al. Usefulness of the admission electrocardiogram to predict long-term outcomes after non-ST-elevation acute coronary syndrome (from the FRISC II, ICTUS, and RITA-3 [FIR] Trials). Am J Cardiol. 2012;109(1):6-12. Abstract
Oliveira GB, Avezum A, Anderson FA, Budaj A, Dabbous OH, Goodman SG, et al. Use of proven therapies in non-ST-elevation acute coronary syndromes according to evidence-based risk stratification. American heart journal. 2007;153:493-9. Abstract
Gore JM, Spencer FA, Goldberg RJ, Kennelly BM, Fox KA, Allegrone J, et al. Use of heparins in Non-ST-elevation acute coronary syndromes. The American journal of medicine. 2007;120:63-71. Abstract
Krimly A, Yan RT, Yan AT, DeYoung PJ, Gallo R, Steg G, et al. Use of Clopidogrel Post-Coronary Artery Bypass Surgery in Canadian Patients With Acute Coronary Syndromes. The Canadian journal of cardiology. 2011. Abstract
Harding SA, Sarma J, Josephs DH, Cruden NL, Din JN, Twomey PJ, et al. Upregulation of the CD40/CD40 ligand dyad and platelet-monocyte aggregation in cigarette smokers. Circulation. 2004;109(16):1926-9. Abstract
Newby DE, Fox KA. Unstable angina: the first 48 hours and later in-hospital management. British medical bulletin. 2001;59:69-87. Abstract
Fox KA, Carruthers KF, Dunbar DR, Graham C, Manning JR, De Raedt H, et al. Underestimated and under-recognized: the late consequences of acute coronary syndrome (GRACE UK-Belgian Study). European heart journal. 2010. Abstract
Alam SR, Shah AS, Richards J, Lang NN, Barnes G, Joshi N, et al. Ultrasmall superparamagnetic particles of iron oxide in patients with acute myocardial infarction: early clinical experience. Circ Cardiovasc Imaging. 2012;5(5):559-65. Abstract
Alam SR, Shah AS, Richards J, Lang NN, Barnes G, Joshi N, et al. Ultrasmall superparamagnetic particles of iron oxide in patients with acute myocardial infarction: early clinical experience. Circ Cardiovasc Imaging. 2012;5(5):559-65. Abstract
T
Eagle KA, Nallamothu BK, Mehta RH, Granger CB, Steg PG, Van de Werf F, et al. Trends in acute reperfusion therapy for ST-segment elevation myocardial infarction from 1999 to 2006: we are getting better but we have got a long way to go. European heart journal. 2008;29:609-17. Abstract
Damman P, van Geloven N, Wallentin L, Lagerqvist B, Fox KA, Clayton T, et al. Timing of Angiography With a Routine Invasive Strategy and Long-Term Outcomes in Non-ST-Segment Elevation Acute Coronary Syndrome: A Collaborative Analysis of Individual Patient Data . JACC Cardiovasc Interv. 2012;5(2):191-9. Abstract
Nyirenda MJ, Clark DN, Finlayson AR, Read J, Elders A, Bain M, et al. Thyroid disease and increased cardiovascular risk. Thyroid : official journal of the American Thyroid Association. 2005;15:718-24. Abstract
Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, et al. Third universal definition of myocardial infarction. Eur Heart J. 2012;33(20):2551-67.